1PPG - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR

Authors :   W. Bode, A-Z. Wei

Date :   24 Oct 91 (Deposition) - 31 Jan 94 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.30

Chains :   Asym. Unit : E,I
Biol. Unit 1: E,I  (3x)
Biol. Unit 2: E,I  (1x)

Keywords :   Serine Proteinase, Hydrolase-Hydrolase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   A. Z. Wei, I. Mayr, W. Bode
The Refined 2. 3 A Crystal Structure Of Human Leukocyte Elastase In A Complex With A Valine Chloromethyl Ketone Inhibitor.
Febs Lett. V. 234 367 1988
PubMed-ID: 3391280 | Reference-DOI: 10.1016/0014-5793(88)80118-2
(for further references see the PDB file header)

Molecule 1 - HUMAN LEUKOCYTE ELASTASE
	Chains	:	E
	EC Number	:	3.4.21.37
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606

Molecule 2 - MEO-SUCCINYL-ALA-ALA-PRO-VAL CHLOROMETHYLKETONE
	Chains	:	I
	Engineered	:	YES
	Synthetic	:	YES

		1	2
Asymmetric Unit	:	E	I
Biological Unit 1 (3x)	:	E	I
Biological Unit 2 (1x)	:	E	I

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (10, 19)

No.	Name	Count	Type	Full Name
1	0QE	1	Mod. Amino Acid	CHLOROMETHANE
2	BMA	3	Ligand/Ion	BETA-D-MANNOSE
3	FUC	2	Ligand/Ion	ALPHA-L-FUCOSE
4	GAL	1	Ligand/Ion	BETA-D-GALACTOSE
5	GLC	1	Ligand/Ion	ALPHA-D-GLUCOSE
6	HMB	1	Mod. Amino Acid	(4S)-4-HYDROXY-4-METHOXYBUTANOIC ACID
7	MAN	3	Ligand/Ion	ALPHA-D-MANNOSE
8	NAG	5	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
9	NDG	1	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
10	VAI	1	Mod. Amino Acid	(2S)-2-AMINO-3-METHYLBUTANE-1,1-DIOL

Biological Unit 1 (10, 57)

No.	Name	Count	Type	Full Name
1	0QE	3	Mod. Amino Acid	CHLOROMETHANE
2	BMA	9	Ligand/Ion	BETA-D-MANNOSE
3	FUC	6	Ligand/Ion	ALPHA-L-FUCOSE
4	GAL	3	Ligand/Ion	BETA-D-GALACTOSE
5	GLC	3	Ligand/Ion	ALPHA-D-GLUCOSE
6	HMB	3	Mod. Amino Acid	(4S)-4-HYDROXY-4-METHOXYBUTANOIC ACID
7	MAN	9	Ligand/Ion	ALPHA-D-MANNOSE
8	NAG	15	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
9	NDG	3	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
10	VAI	3	Mod. Amino Acid	(2S)-2-AMINO-3-METHYLBUTANE-1,1-DIOL

Biological Unit 2 (10, 19)

No.	Name	Count	Type	Full Name
1	0QE	1	Mod. Amino Acid	CHLOROMETHANE
2	BMA	3	Ligand/Ion	BETA-D-MANNOSE
3	FUC	2	Ligand/Ion	ALPHA-L-FUCOSE
4	GAL	1	Ligand/Ion	BETA-D-GALACTOSE
5	GLC	1	Ligand/Ion	ALPHA-D-GLUCOSE
6	HMB	1	Mod. Amino Acid	(4S)-4-HYDROXY-4-METHOXYBUTANOIC ACID
7	MAN	3	Ligand/Ion	ALPHA-D-MANNOSE
8	NAG	5	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
9	NDG	1	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
10	VAI	1	Mod. Amino Acid	(2S)-2-AMINO-3-METHYLBUTANE-1,1-DIOL

Asymmetric Unit (3, 3)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	VAL E:64 , ARG E:65 , VAL E:82 , ALA E:84 , ASN E:109 , HOH E:677 , HOH E:1247	BINDING SITE FOR CHAIN E OF SUGAR BOUND TO ASN E 109 RESIDUES 411 TO 418
2	AC2	SOFTWARE	ILE E:16 , VAL E:17 , GLY E:18 , GLY E:19 , ARG E:20 , ARG E:21 , ALA E:22 , ARG E:23 , HIS E:25 , TRP E:27 , PRO E:28 , PHE E:29 , MET E:30 , VAL E:31 , ARG E:36 , HIS E:40 , PHE E:41 , CYS E:42 , GLY E:43 , ALA E:44 , THR E:45 , LEU E:46 , ILE E:47 , ALA E:48 , PRO E:49 , ASN E:50 , PHE E:51 , VAL E:52 , MET E:53 , SER E:54 , ALA E:55 , ALA E:56 , HIS E:57 , CYS E:58 , VAL E:66 , LEU E:68 , GLY E:69 , HIS E:71 , ASN E:72 , LEU E:73 , THR E:79 , GLN E:81 , PHE E:83 , ALA E:84 , VAL E:85 , GLN E:86 , ARG E:87 , ILE E:88 , PHE E:89 , GLU E:90 , ASN E:92 , GLY E:93 , TYR E:94 , ASP E:95 , PRO E:96 , VAL E:97 , NAG E:411 , HOH E:505 , HOH E:506 , HOH E:508 , HOH E:509 , HOH E:513 , HOH E:520 , HOH E:523 , HOH E:528 , HOH E:530 , HOH E:537 , HOH E:548 , HOH E:549 , HOH E:550 , HOH E:552 , HOH E:554 , HOH E:557 , HOH E:560 , HOH E:564 , HOH E:567 , HOH E:568 , HOH E:571 , HOH E:572 , HOH E:592 , HOH E:594 , HOH E:595 , HOH E:599 , HOH E:602 , HOH E:613 , HOH E:621 , HOH E:622 , HOH E:624 , HOH E:629 , HOH E:636 , HOH E:651 , HOH E:659 , HOH E:663 , HOH E:689 , HOH E:696 , HOH E:697 , HOH E:702 , HOH E:703 , HOH E:708 , HOH E:711 , HOH E:737 , HOH E:758 , HOH E:762 , HOH E:773 , HOH E:776 , HOH E:781 , HOH E:788 , HOH E:789 , HOH E:846 , HOH E:866 , HOH E:867 , HOH E:877 , HOH E:901 , HOH E:902 , HOH E:907 , HOH E:915 , HOH E:922 , HOH E:927 , HOH E:967 , HOH E:968 , HOH E:979 , HOH E:997 , HOH E:1099 , HOH E:1107 , HOH E:1163 , HOH E:1165 , HOH E:1239 , HOH E:1269 , HOH E:1271 , HOH E:1273 , HMB I:1 , ALA I:2 , ALA I:3 , PRO I:4 , 0QE I:6	BINDING SITE FOR CHAIN E OF SUGAR BOUND TO ASN E 159 RESIDUES 98 TO 408
3	AC3	SOFTWARE	HIS E:57 , CYS E:191 , PHE E:192 , GLY E:193 , SER E:195 , SER E:214 , PHE E:215 , VAL E:216 , ARG E:217 , GLY E:218 , GLY E:219 , HOH E:636 , HOH E:715	BINDING SITE FOR CHAIN I OF MEO-SUCCINYL-ALA-ALA -PRO-VAL CHLOROMETHYLKETONE

Asymmetric Unit

No.	Residues
1	E:42	-	E:58
2	E:136	-	E:201
3	E:168	-	E:182
4	E:191	-	E:220

(no "Cis Peptide Bond" information available for 1PPG)

Asymmetric Unit (85, 85)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_070696	P	42	L	ELNE_HUMAN	Disease (SCN1)	---	E	P	28	L
02	UniProt	VAR_070697	F	43	L	ELNE_HUMAN	Disease (SCN1)	---	E	F	29	L
03	UniProt	VAR_070698	M	44	R	ELNE_HUMAN	Disease (SCN1)	---	E	M	30	R
04	UniProt	VAR_070699	V	45	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	31	E
05	UniProt	VAR_070700	V	45	L	ELNE_HUMAN	Disease (CH)	---	E	V	31	L
06	UniProt	VAR_070701	S	46	C	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	C
07	UniProt	VAR_070702	S	46	F	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	F
08	UniProt	VAR_070703	L	47	P	ELNE_HUMAN	Disease (SCN1)	878855319	E	L	33	P
09	UniProt	VAR_070704	L	47	R	ELNE_HUMAN	Disease (SCN1)	---	E	L	33	R
10	UniProt	VAR_070705	L	49	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	35	P
11	UniProt	VAR_070706	H	53	L	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	L
12	UniProt	VAR_070707	H	53	Q	ELNE_HUMAN	Disease (CH)	---	E	H	40	Q
13	UniProt	VAR_070708	H	53	Y	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	Y
14	UniProt	VAR_070709	C	55	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	S
15	UniProt	VAR_038609	C	55	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	Y
16	UniProt	VAR_070710	G	56	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	43	R
17	UniProt	VAR_070711	A	57	S	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	S
18	UniProt	VAR_038610	A	57	T	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	T
19	UniProt	VAR_070712	A	57	V	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	V
20	UniProt	VAR_070713	L	59	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	46	P
21	UniProt	VAR_038611	I	60	T	ELNE_HUMAN	Disease (SCN1)	---	E	I	47	T
22	UniProt	VAR_070715	A	61	V	ELNE_HUMAN	Disease (SCN1)	137854447	E	A	48	V
23	UniProt	VAR_070718	S	67	W	ELNE_HUMAN	Disease (SCN1)	---	E	S	54	W
24	UniProt	VAR_070719	C	71	F	ELNE_HUMAN	Disease (SCN1)	878855315	E	C	58	F
25	UniProt	VAR_038612	C	71	R	ELNE_HUMAN	Disease (SCN1)	28931611	E	C	58	R
26	UniProt	VAR_038613	C	71	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	S
27	UniProt	VAR_070720	C	71	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	Y
28	UniProt	VAR_070721	V	72	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	59	G
29	UniProt	VAR_070722	V	80	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	64	G
30	UniProt	VAR_070723	R	81	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	65	P
31	UniProt	VAR_070724	V	82	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	66	M
32	UniProt	VAR_070725	L	84	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	68	P
33	UniProt	VAR_038614	G	85	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	E
34	UniProt	VAR_070726	G	85	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	R
35	UniProt	VAR_070727	Q	97	L	ELNE_HUMAN	Disease (CH)	---	E	Q	81	L
36	UniProt	VAR_038615	V	98	L	ELNE_HUMAN	Disease (SCN1)	267606781	E	V	82	L
37	UniProt	VAR_070728	V	98	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	82	M
38	UniProt	VAR_038616	V	101	L	ELNE_HUMAN	Disease (SCN1)	137854449	E	V	85	L
39	UniProt	VAR_038617	V	101	M	ELNE_HUMAN	Disease (SCN1)	28929494	E	V	85	M
40	UniProt	VAR_070729	R	103	L	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	L
41	UniProt	VAR_070730	R	103	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	P
42	UniProt	VAR_070731	I	104	N	ELNE_HUMAN	Disease (CH)	---	E	I	88	N
43	UniProt	VAR_070732	I	118	V	ELNE_HUMAN	Polymorphism	---	E	I	103	V
44	UniProt	VAR_070733	I	120	F	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	F
45	UniProt	VAR_070734	I	120	N	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	N
46	UniProt	VAR_070735	I	120	S	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	S
47	UniProt	VAR_070736	L	121	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	106	P
48	UniProt	VAR_070737	L	123	H	ELNE_HUMAN	Disease (SCN1)	---	E	L	108	H
49	UniProt	VAR_070738	N	124	I	ELNE_HUMAN	Disease (SCN1)	---	E	N	109	I
50	UniProt	VAR_070739	G	125	R	ELNE_HUMAN	Polymorphism	377698556	E	G	110	R
51	UniProt	VAR_038619	S	126	L	ELNE_HUMAN	Disease (SCN1)	137854450	E	S	111	L
52	UniProt	VAR_070740	A	127	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	D
53	UniProt	VAR_070741	A	127	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	P
54	UniProt	VAR_070742	A	131	T	ELNE_HUMAN	Unclassified (SCN1)	201729066	E	A	116	T
55	UniProt	VAR_070743	V	135	M	ELNE_HUMAN	Polymorphism	774457980	E	V	120	M
56	UniProt	VAR_070744	A	136	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	121	D
57	UniProt	VAR_038620	P	139	L	ELNE_HUMAN	Disease (SCN1)	28929493	E	P	124	L
58	UniProt	VAR_070745	P	139	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	124	R
59	UniProt	VAR_070746	R	143	H	ELNE_HUMAN	Unclassified (CH)	200993994	E	R	128	H
60	UniProt	VAR_070747	C	151	F	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	F
61	UniProt	VAR_038621	C	151	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	S
62	UniProt	VAR_070748	C	151	W	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	W
63	UniProt	VAR_070749	C	151	Y	ELNE_HUMAN	Unclassified (SCN1)	57246956	E	C	136	Y
64	UniProt	VAR_070750	L	152	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	137	P
65	UniProt	VAR_070751	A	153	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	D
66	UniProt	VAR_070752	A	153	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	P
67	UniProt	VAR_070753	W	156	C	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	C
68	UniProt	VAR_070754	W	156	R	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	R
69	UniProt	VAR_064513	A	166	T	ELNE_HUMAN	Disease (SCN1)	201788817	E	A	152	T
70	UniProt	VAR_070755	G	203	C	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	C
71	UniProt	VAR_070756	G	203	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	R
72	UniProt	VAR_038623	P	205	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	198	R
73	UniProt	VAR_070757	L	206	F	ELNE_HUMAN	Disease (CH)	137854446	E	L	199	F
74	UniProt	VAR_070758	L	206	S	ELNE_HUMAN	Disease (SCN1)	---	E	L	199	S
75	UniProt	VAR_070759	C	208	G	ELNE_HUMAN	Disease (SCN1)	---	E	C	201	G
76	UniProt	VAR_070760	N	209	I	ELNE_HUMAN	Disease (CH)	---	E	N	202	I
77	UniProt	VAR_038624	G	210	V	ELNE_HUMAN	Disease (SCN1)	---	E	G	207	V
78	UniProt	VAR_070761	G	210	W	ELNE_HUMAN	Disease (CH)	---	E	G	207	W
79	UniProt	VAR_070762	G	214	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	211	E
80	UniProt	VAR_038625	G	214	R	ELNE_HUMAN	Disease (SCN1)	137854451	E	G	211	R
81	UniProt	VAR_019237	V	219	I	ELNE_HUMAN	Unclassified (SCN1)	17216656	E	V	216	I
82	UniProt	VAR_070763	R	220	Q	ELNE_HUMAN	Disease (SCN1)	137854445	E	R	217	Q
83	UniProt	VAR_070764	A	233	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	229	P
84	UniProt	VAR_070765	V	235	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	E
85	UniProt	VAR_070766	V	235	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	G

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (85, 255)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_070696	P	42	L	ELNE_HUMAN	Disease (SCN1)	---	E	P	28	L
02	UniProt	VAR_070697	F	43	L	ELNE_HUMAN	Disease (SCN1)	---	E	F	29	L
03	UniProt	VAR_070698	M	44	R	ELNE_HUMAN	Disease (SCN1)	---	E	M	30	R
04	UniProt	VAR_070699	V	45	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	31	E
05	UniProt	VAR_070700	V	45	L	ELNE_HUMAN	Disease (CH)	---	E	V	31	L
06	UniProt	VAR_070701	S	46	C	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	C
07	UniProt	VAR_070702	S	46	F	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	F
08	UniProt	VAR_070703	L	47	P	ELNE_HUMAN	Disease (SCN1)	878855319	E	L	33	P
09	UniProt	VAR_070704	L	47	R	ELNE_HUMAN	Disease (SCN1)	---	E	L	33	R
10	UniProt	VAR_070705	L	49	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	35	P
11	UniProt	VAR_070706	H	53	L	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	L
12	UniProt	VAR_070707	H	53	Q	ELNE_HUMAN	Disease (CH)	---	E	H	40	Q
13	UniProt	VAR_070708	H	53	Y	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	Y
14	UniProt	VAR_070709	C	55	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	S
15	UniProt	VAR_038609	C	55	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	Y
16	UniProt	VAR_070710	G	56	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	43	R
17	UniProt	VAR_070711	A	57	S	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	S
18	UniProt	VAR_038610	A	57	T	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	T
19	UniProt	VAR_070712	A	57	V	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	V
20	UniProt	VAR_070713	L	59	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	46	P
21	UniProt	VAR_038611	I	60	T	ELNE_HUMAN	Disease (SCN1)	---	E	I	47	T
22	UniProt	VAR_070715	A	61	V	ELNE_HUMAN	Disease (SCN1)	137854447	E	A	48	V
23	UniProt	VAR_070718	S	67	W	ELNE_HUMAN	Disease (SCN1)	---	E	S	54	W
24	UniProt	VAR_070719	C	71	F	ELNE_HUMAN	Disease (SCN1)	878855315	E	C	58	F
25	UniProt	VAR_038612	C	71	R	ELNE_HUMAN	Disease (SCN1)	28931611	E	C	58	R
26	UniProt	VAR_038613	C	71	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	S
27	UniProt	VAR_070720	C	71	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	Y
28	UniProt	VAR_070721	V	72	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	59	G
29	UniProt	VAR_070722	V	80	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	64	G
30	UniProt	VAR_070723	R	81	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	65	P
31	UniProt	VAR_070724	V	82	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	66	M
32	UniProt	VAR_070725	L	84	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	68	P
33	UniProt	VAR_038614	G	85	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	E
34	UniProt	VAR_070726	G	85	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	R
35	UniProt	VAR_070727	Q	97	L	ELNE_HUMAN	Disease (CH)	---	E	Q	81	L
36	UniProt	VAR_038615	V	98	L	ELNE_HUMAN	Disease (SCN1)	267606781	E	V	82	L
37	UniProt	VAR_070728	V	98	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	82	M
38	UniProt	VAR_038616	V	101	L	ELNE_HUMAN	Disease (SCN1)	137854449	E	V	85	L
39	UniProt	VAR_038617	V	101	M	ELNE_HUMAN	Disease (SCN1)	28929494	E	V	85	M
40	UniProt	VAR_070729	R	103	L	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	L
41	UniProt	VAR_070730	R	103	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	P
42	UniProt	VAR_070731	I	104	N	ELNE_HUMAN	Disease (CH)	---	E	I	88	N
43	UniProt	VAR_070732	I	118	V	ELNE_HUMAN	Polymorphism	---	E	I	103	V
44	UniProt	VAR_070733	I	120	F	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	F
45	UniProt	VAR_070734	I	120	N	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	N
46	UniProt	VAR_070735	I	120	S	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	S
47	UniProt	VAR_070736	L	121	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	106	P
48	UniProt	VAR_070737	L	123	H	ELNE_HUMAN	Disease (SCN1)	---	E	L	108	H
49	UniProt	VAR_070738	N	124	I	ELNE_HUMAN	Disease (SCN1)	---	E	N	109	I
50	UniProt	VAR_070739	G	125	R	ELNE_HUMAN	Polymorphism	377698556	E	G	110	R
51	UniProt	VAR_038619	S	126	L	ELNE_HUMAN	Disease (SCN1)	137854450	E	S	111	L
52	UniProt	VAR_070740	A	127	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	D
53	UniProt	VAR_070741	A	127	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	P
54	UniProt	VAR_070742	A	131	T	ELNE_HUMAN	Unclassified (SCN1)	201729066	E	A	116	T
55	UniProt	VAR_070743	V	135	M	ELNE_HUMAN	Polymorphism	774457980	E	V	120	M
56	UniProt	VAR_070744	A	136	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	121	D
57	UniProt	VAR_038620	P	139	L	ELNE_HUMAN	Disease (SCN1)	28929493	E	P	124	L
58	UniProt	VAR_070745	P	139	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	124	R
59	UniProt	VAR_070746	R	143	H	ELNE_HUMAN	Unclassified (CH)	200993994	E	R	128	H
60	UniProt	VAR_070747	C	151	F	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	F
61	UniProt	VAR_038621	C	151	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	S
62	UniProt	VAR_070748	C	151	W	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	W
63	UniProt	VAR_070749	C	151	Y	ELNE_HUMAN	Unclassified (SCN1)	57246956	E	C	136	Y
64	UniProt	VAR_070750	L	152	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	137	P
65	UniProt	VAR_070751	A	153	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	D
66	UniProt	VAR_070752	A	153	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	P
67	UniProt	VAR_070753	W	156	C	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	C
68	UniProt	VAR_070754	W	156	R	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	R
69	UniProt	VAR_064513	A	166	T	ELNE_HUMAN	Disease (SCN1)	201788817	E	A	152	T
70	UniProt	VAR_070755	G	203	C	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	C
71	UniProt	VAR_070756	G	203	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	R
72	UniProt	VAR_038623	P	205	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	198	R
73	UniProt	VAR_070757	L	206	F	ELNE_HUMAN	Disease (CH)	137854446	E	L	199	F
74	UniProt	VAR_070758	L	206	S	ELNE_HUMAN	Disease (SCN1)	---	E	L	199	S
75	UniProt	VAR_070759	C	208	G	ELNE_HUMAN	Disease (SCN1)	---	E	C	201	G
76	UniProt	VAR_070760	N	209	I	ELNE_HUMAN	Disease (CH)	---	E	N	202	I
77	UniProt	VAR_038624	G	210	V	ELNE_HUMAN	Disease (SCN1)	---	E	G	207	V
78	UniProt	VAR_070761	G	210	W	ELNE_HUMAN	Disease (CH)	---	E	G	207	W
79	UniProt	VAR_070762	G	214	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	211	E
80	UniProt	VAR_038625	G	214	R	ELNE_HUMAN	Disease (SCN1)	137854451	E	G	211	R
81	UniProt	VAR_019237	V	219	I	ELNE_HUMAN	Unclassified (SCN1)	17216656	E	V	216	I
82	UniProt	VAR_070763	R	220	Q	ELNE_HUMAN	Disease (SCN1)	137854445	E	R	217	Q
83	UniProt	VAR_070764	A	233	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	229	P
84	UniProt	VAR_070765	V	235	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	E
85	UniProt	VAR_070766	V	235	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	G

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (85, 85)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_070696	P	42	L	ELNE_HUMAN	Disease (SCN1)	---	E	P	28	L
02	UniProt	VAR_070697	F	43	L	ELNE_HUMAN	Disease (SCN1)	---	E	F	29	L
03	UniProt	VAR_070698	M	44	R	ELNE_HUMAN	Disease (SCN1)	---	E	M	30	R
04	UniProt	VAR_070699	V	45	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	31	E
05	UniProt	VAR_070700	V	45	L	ELNE_HUMAN	Disease (CH)	---	E	V	31	L
06	UniProt	VAR_070701	S	46	C	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	C
07	UniProt	VAR_070702	S	46	F	ELNE_HUMAN	Disease (SCN1)	---	E	S	32	F
08	UniProt	VAR_070703	L	47	P	ELNE_HUMAN	Disease (SCN1)	878855319	E	L	33	P
09	UniProt	VAR_070704	L	47	R	ELNE_HUMAN	Disease (SCN1)	---	E	L	33	R
10	UniProt	VAR_070705	L	49	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	35	P
11	UniProt	VAR_070706	H	53	L	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	L
12	UniProt	VAR_070707	H	53	Q	ELNE_HUMAN	Disease (CH)	---	E	H	40	Q
13	UniProt	VAR_070708	H	53	Y	ELNE_HUMAN	Disease (SCN1)	---	E	H	40	Y
14	UniProt	VAR_070709	C	55	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	S
15	UniProt	VAR_038609	C	55	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	42	Y
16	UniProt	VAR_070710	G	56	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	43	R
17	UniProt	VAR_070711	A	57	S	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	S
18	UniProt	VAR_038610	A	57	T	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	T
19	UniProt	VAR_070712	A	57	V	ELNE_HUMAN	Disease (SCN1)	---	E	A	44	V
20	UniProt	VAR_070713	L	59	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	46	P
21	UniProt	VAR_038611	I	60	T	ELNE_HUMAN	Disease (SCN1)	---	E	I	47	T
22	UniProt	VAR_070715	A	61	V	ELNE_HUMAN	Disease (SCN1)	137854447	E	A	48	V
23	UniProt	VAR_070718	S	67	W	ELNE_HUMAN	Disease (SCN1)	---	E	S	54	W
24	UniProt	VAR_070719	C	71	F	ELNE_HUMAN	Disease (SCN1)	878855315	E	C	58	F
25	UniProt	VAR_038612	C	71	R	ELNE_HUMAN	Disease (SCN1)	28931611	E	C	58	R
26	UniProt	VAR_038613	C	71	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	S
27	UniProt	VAR_070720	C	71	Y	ELNE_HUMAN	Disease (SCN1)	---	E	C	58	Y
28	UniProt	VAR_070721	V	72	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	59	G
29	UniProt	VAR_070722	V	80	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	64	G
30	UniProt	VAR_070723	R	81	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	65	P
31	UniProt	VAR_070724	V	82	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	66	M
32	UniProt	VAR_070725	L	84	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	68	P
33	UniProt	VAR_038614	G	85	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	E
34	UniProt	VAR_070726	G	85	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	69	R
35	UniProt	VAR_070727	Q	97	L	ELNE_HUMAN	Disease (CH)	---	E	Q	81	L
36	UniProt	VAR_038615	V	98	L	ELNE_HUMAN	Disease (SCN1)	267606781	E	V	82	L
37	UniProt	VAR_070728	V	98	M	ELNE_HUMAN	Disease (SCN1)	---	E	V	82	M
38	UniProt	VAR_038616	V	101	L	ELNE_HUMAN	Disease (SCN1)	137854449	E	V	85	L
39	UniProt	VAR_038617	V	101	M	ELNE_HUMAN	Disease (SCN1)	28929494	E	V	85	M
40	UniProt	VAR_070729	R	103	L	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	L
41	UniProt	VAR_070730	R	103	P	ELNE_HUMAN	Disease (SCN1)	---	E	R	87	P
42	UniProt	VAR_070731	I	104	N	ELNE_HUMAN	Disease (CH)	---	E	I	88	N
43	UniProt	VAR_070732	I	118	V	ELNE_HUMAN	Polymorphism	---	E	I	103	V
44	UniProt	VAR_070733	I	120	F	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	F
45	UniProt	VAR_070734	I	120	N	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	N
46	UniProt	VAR_070735	I	120	S	ELNE_HUMAN	Disease (SCN1)	---	E	I	105	S
47	UniProt	VAR_070736	L	121	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	106	P
48	UniProt	VAR_070737	L	123	H	ELNE_HUMAN	Disease (SCN1)	---	E	L	108	H
49	UniProt	VAR_070738	N	124	I	ELNE_HUMAN	Disease (SCN1)	---	E	N	109	I
50	UniProt	VAR_070739	G	125	R	ELNE_HUMAN	Polymorphism	377698556	E	G	110	R
51	UniProt	VAR_038619	S	126	L	ELNE_HUMAN	Disease (SCN1)	137854450	E	S	111	L
52	UniProt	VAR_070740	A	127	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	D
53	UniProt	VAR_070741	A	127	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	112	P
54	UniProt	VAR_070742	A	131	T	ELNE_HUMAN	Unclassified (SCN1)	201729066	E	A	116	T
55	UniProt	VAR_070743	V	135	M	ELNE_HUMAN	Polymorphism	774457980	E	V	120	M
56	UniProt	VAR_070744	A	136	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	121	D
57	UniProt	VAR_038620	P	139	L	ELNE_HUMAN	Disease (SCN1)	28929493	E	P	124	L
58	UniProt	VAR_070745	P	139	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	124	R
59	UniProt	VAR_070746	R	143	H	ELNE_HUMAN	Unclassified (CH)	200993994	E	R	128	H
60	UniProt	VAR_070747	C	151	F	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	F
61	UniProt	VAR_038621	C	151	S	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	S
62	UniProt	VAR_070748	C	151	W	ELNE_HUMAN	Disease (SCN1)	---	E	C	136	W
63	UniProt	VAR_070749	C	151	Y	ELNE_HUMAN	Unclassified (SCN1)	57246956	E	C	136	Y
64	UniProt	VAR_070750	L	152	P	ELNE_HUMAN	Disease (SCN1)	---	E	L	137	P
65	UniProt	VAR_070751	A	153	D	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	D
66	UniProt	VAR_070752	A	153	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	138	P
67	UniProt	VAR_070753	W	156	C	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	C
68	UniProt	VAR_070754	W	156	R	ELNE_HUMAN	Disease (SCN1)	---	E	W	141	R
69	UniProt	VAR_064513	A	166	T	ELNE_HUMAN	Disease (SCN1)	201788817	E	A	152	T
70	UniProt	VAR_070755	G	203	C	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	C
71	UniProt	VAR_070756	G	203	R	ELNE_HUMAN	Disease (SCN1)	---	E	G	196	R
72	UniProt	VAR_038623	P	205	R	ELNE_HUMAN	Disease (SCN1)	---	E	P	198	R
73	UniProt	VAR_070757	L	206	F	ELNE_HUMAN	Disease (CH)	137854446	E	L	199	F
74	UniProt	VAR_070758	L	206	S	ELNE_HUMAN	Disease (SCN1)	---	E	L	199	S
75	UniProt	VAR_070759	C	208	G	ELNE_HUMAN	Disease (SCN1)	---	E	C	201	G
76	UniProt	VAR_070760	N	209	I	ELNE_HUMAN	Disease (CH)	---	E	N	202	I
77	UniProt	VAR_038624	G	210	V	ELNE_HUMAN	Disease (SCN1)	---	E	G	207	V
78	UniProt	VAR_070761	G	210	W	ELNE_HUMAN	Disease (CH)	---	E	G	207	W
79	UniProt	VAR_070762	G	214	E	ELNE_HUMAN	Disease (SCN1)	---	E	G	211	E
80	UniProt	VAR_038625	G	214	R	ELNE_HUMAN	Disease (SCN1)	137854451	E	G	211	R
81	UniProt	VAR_019237	V	219	I	ELNE_HUMAN	Unclassified (SCN1)	17216656	E	V	216	I
82	UniProt	VAR_070763	R	220	Q	ELNE_HUMAN	Disease (SCN1)	137854445	E	R	217	Q
83	UniProt	VAR_070764	A	233	P	ELNE_HUMAN	Disease (SCN1)	---	E	A	229	P
84	UniProt	VAR_070765	V	235	E	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	E
85	UniProt	VAR_070766	V	235	G	ELNE_HUMAN	Disease (SCN1)	---	E	V	231	G

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (3, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	TRYPSIN_DOM	PS50240	Serine proteases, trypsin domain profile.	ELNE_HUMAN	30-247	1	E:16-243
2	TRYPSIN_HIS	PS00134	Serine proteases, trypsin family, histidine active site.	ELNE_HUMAN	66-71	1	E:53-58
3	TRYPSIN_SER	PS00135	Serine proteases, trypsin family, serine active site.	ELNE_HUMAN	196-207	1	E:189-200

Biological Unit 1 (3, 9)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	TRYPSIN_DOM	PS50240	Serine proteases, trypsin domain profile.	ELNE_HUMAN	30-247	3	E:16-243
2	TRYPSIN_HIS	PS00134	Serine proteases, trypsin family, histidine active site.	ELNE_HUMAN	66-71	3	E:53-58
3	TRYPSIN_SER	PS00135	Serine proteases, trypsin family, serine active site.	ELNE_HUMAN	196-207	3	E:189-200

Biological Unit 2 (3, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	TRYPSIN_DOM	PS50240	Serine proteases, trypsin domain profile.	ELNE_HUMAN	30-247	1	E:16-243
2	TRYPSIN_HIS	PS00134	Serine proteases, trypsin family, histidine active site.	ELNE_HUMAN	66-71	1	E:53-58
3	TRYPSIN_SER	PS00135	Serine proteases, trypsin family, serine active site.	ELNE_HUMAN	196-207	1	E:189-200

Asymmetric Unit (4, 4)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1	ENST00000263621	1	ENSE00000892229	chr19:852291-852395	105	ELNE_HUMAN	1-23	23	0	-	-
1.2	ENST00000263621	2	ENSE00000768824	chr19:852876-853032	157	ELNE_HUMAN	23-75	53	1	E:16-62 (gaps)	47
1.3	ENST00000263621	3	ENSE00000768826	chr19:853262-853403	142	ELNE_HUMAN	75-122	48	1	E:62-107 (gaps)	49
1.4	ENST00000263621	4	ENSE00000768828	chr19:855564-855794	231	ELNE_HUMAN	123-199	77	1	E:108-192 (gaps)	87
1.5	ENST00000263621	5	ENSE00000892230	chr19:855958-856242	285	ELNE_HUMAN	200-267	68	1	E:193-243 (gaps)	52

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain E from PDB  Type:PROTEIN  Length:218
 aligned with ELNE_HUMAN | P08246 from UniProtKB/Swiss-Prot  Length:267

    Alignment length:218
                                    39        49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239        
          ELNE_HUMAN     30 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  247
               SCOP domains d1ppge_ E: Elastase                                                                                                                                                                                                        SCOP domains
               CATH domains 1ppgE01     1ppgE02 E:28-120,E:233-243 Trypsin-like serine proteases                                      1ppgE01 E:16-27,E:121-232 Trypsin-like serine proteases                                              1ppgE02     CATH domains
               Pfam domains Trypsin-1ppgE01 E:16-238                                                                                                                                                                                             ----- Pfam domains
         Sec.struct. author ............eeeeeeeeeeeeeeeeeeeeeeeeeehhhhhh..hhhhh.eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee.......................eeeeeeeeeeeeeeeeeeeeeeeeeeeeee........eeee..............eeeeeeeeeeeeeee...........eeeehhhhhhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) ------------LLRECP-P---L-SRS-PTV-----W---FG-------GPM-PE-----------LL--L-LN-------------V-FP-HIRLD---T---MD--L---H-------FPD--C---------T------------------------------------C-RF-GIV---E----IQ------------P-E------------ SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------LFR-----Q-Y-T-------------R-------------R------------M--M-P----------------N------P-----------R-----------S-P--R----------------------------------------------R--S---W---R--------------------G------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------Y---V-------------S------------------------------------------------S------------------------------W------------------------------------------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------Y-------------------------------------------------------------------------------Y------------------------------------------------------------------------------------------------ SAPs(SNPs) (4)
                PROSITE (1) TRYPSIN_DOM  PDB: E:16-243 UniProt: 30-247                                                                                                                                                                                 PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ---------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.2  PDB: E:16-62 (gaps) UniProt: 23-75  -----------------------------------------------Exon 1.4  PDB: E:108-192 (gaps) UniProt: 123-199                             Exon 1.5  PDB: E:193-243 (gaps) UniProt: 200-267 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------Exon 1.3  PDB: E:62-107 (gaps) UniProt: 75-122  ----------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                1ppg E   16 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  243
                                    25        35||      46        56       63C        73        83      ||94       104       114       124       134       144   ||  155       165|||    184  ||   192       202|      216    |  225       235        
                                               36|                       63A||                         90|                                                     148|             166||      186A|             202|          220A                       
                                                38                        63B|                          92                                                      150              168|       186B              207                                     
                                                                           63C                                                                                                    177

Chain I from PDB  Type:PROTEIN  Length:6
                                       
               SCOP domains ------ SCOP domains
               CATH domains ------ CATH domains
               Pfam domains ------ Pfam domains
         Sec.struct. author ...... Sec.struct. author
                 SAPs(SNPs) ------ SAPs(SNPs)
                    PROSITE ------ PROSITE
                 Transcript ------ Transcript
                1ppg I    1 xAAPvx    6
                            |   ||
                            1-HMB|
                                5-VAI
                                 6-0QE

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: All beta proteins (24004)

Fold: Trypsin-like serine proteases (1752)

Superfamily: Trypsin-like serine proteases (1752)

Family: Eukaryotic proteases (1343)

Protein domain: Elastase (123)

Human (Homo sapiens) [TaxId: 9606] (5)

d1ppge_

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Mainly Beta (13760)

Architecture: Beta Barrel (4804)

Topology: Thrombin, subunit H (1535)

Homologous Superfamily: Trypsin-like serine proteases (1488)

2_ (2)

1a	1ppgE01	E:16-27,E:121-232
1b	1ppgE02	E:28-120,E:233-243

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Peptidase_PA (797)

Family: Trypsin (679)

Homo sapiens (Human) (339)

Trypsin-1ppgE01

E:16-238

Asymmetric Unit(hide GO term definitions)

Chain E (ELNE_HUMAN | P08246)

molecular function
	GO:0001106	RNA polymerase II transcription corepressor activity	Interacting selectively and non-covalently with an RNA polymerase II repressing transcription factor and also with the RNA polymerase II basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
	GO:0019955	cytokine binding	Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
	GO:0004175	endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008236	serine-type peptidase activity	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
	GO:0002438	acute inflammatory response to antigenic stimulus	An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
	GO:0006874	cellular calcium ion homeostasis	Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.
	GO:0042742	defense response to bacterium	Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
	GO:0050832	defense response to fungus	Reactions triggered in response to the presence of a fungus that act to protect the cell or organism.
	GO:0022617	extracellular matrix disassembly	A process that results in the breakdown of the extracellular matrix.
	GO:0050900	leukocyte migration	The movement of a leukocyte within or between different tissues and organs of the body.
	GO:0045079	negative regulation of chemokine biosynthetic process	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.
	GO:0050922	negative regulation of chemotaxis	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
	GO:0044130	negative regulation of growth of symbiont in host	Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0045415	negative regulation of interleukin-8 biosynthetic process	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0070947	neutrophil mediated killing of fungus	The directed killing of a fungal cell by a neutrophil.
	GO:0006909	phagocytosis	An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
	GO:0043406	positive regulation of MAP kinase activity	Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
	GO:0050778	positive regulation of immune response	Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
	GO:0045416	positive regulation of interleukin-8 biosynthetic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
	GO:0048661	positive regulation of smooth muscle cell proliferation	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
	GO:0030163	protein catabolic process	The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0009411	response to UV	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0001878	response to yeast	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species.
cellular component
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0030141	secretory granule	A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
	GO:0017053	transcriptional repressor complex	A protein complex that possesses activity that prevents or downregulates transcription.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		0QE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GAL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GLC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		HMB	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		VAI	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 1ppg)

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1ppg
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ELNE_HUMAN \| P08246
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.4.21.37
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	162800
		Disease Information	:	OMIM
	202700
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ELNE_HUMAN \| P08246
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Related Entries Specified in the PDB File" available for 1PPG)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (10, 19)

Sites (3, 3)

SS Bonds (4, 4)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (85, 85)

PROSITE Motifs (3, 3)

Exons (4, 4)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (1, 2)

Pfam Domains (1, 1)

Gene Ontology (40, 40)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File